HARMONET

This brand name is authorized in Brazil, Estonia, Finland, France, Hong Kong SAR China, Israel, Lithuania, Poland, Romania, Spain, Tunisia.

Active ingredients

The drug HARMONET contains a combination of these active pharmaceutical ingredients (APIs):

1	Gestodene UNII 1664P6E6MI - GESTODENE
	Read more about Gestodene
2	17 alpha-Ethinylestradiol UNII 423D2T571U - ETHINYL ESTRADIOL
	Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.
	Read more about 17 alpha-Ethinylestradiol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03AA10	Gestodene and ethinylestradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AA Progestogens and estrogens, fixed combinations
Discover more medicines within G03AA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	522701402116411
EE	Ravimiamet	1027718, 1062953
ES	Centro de información online de medicamentos de la AEMPS	2493781-2493682, 428IS187F3, 61975
FI	Lääkealan turvallisuus- ja kehittämiskeskus	062935
FR	Base de données publique des médicaments	67402230
HK	Department of Health Drug Office	44340
IL	מִשְׂרַד הַבְּרִיאוּת	4086, 4087
LT	Valstybinė vaistų kontrolės tarnyba	1015579, 1015580, 1067268
PL	Rejestru Produktów Leczniczych	100094185, 100161800, 100244963, 100264575, 100266462, 100358431, 100403953, 100418713, 100425498
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65040001, W65040002
TN	Direction de la Pharmacie et du Médicament	5803121